Tokyo, Japan—Tosoh Corporation, as part of expanding and strengthening its Bioscience operations, has acquired Indian in-vitro diagnostics company Lilac Medicare Pvt. Ltd. (below, “Lilac”) to become part of the Tosoh Group. Since being established in 1997, Lilac’s products have become well known throughout India. By utilizing the network Lilac has built, Tosoh will make further efforts to increase its share in the growing Indian market by using its own immunological and diabetes diagnostic analyzers as stepping stones towards expanding its Bioscience business and establishing a firm position in India.
Following is a summary of Lilac Medicare Pvt. Ltd.
| Date of establishment | March 1997 |
| Main office location | Navi Mumbai, India |
| Principle shareholders and equity % | Tosoh Group 100% |
| Number of employees | 135 |
| Business summary | Manufacture and sale of clinical diagnostic equipment and reagents
|
| Lilac customer service center |
TOSOH CORPORATION
WHO WE ARE
Tosoh Corporation is the parent of the Tosoh Group, which comprises 130 companies worldwide and a multiethnic workforce of over 11,000 people and generated net sales of ¥772.3 billion (US$7.5 billion at the year-end rate of ¥100.17 to the US dollar) in fiscal 2014, ended March 31, 2014.
WHAT WE DO
Tosoh is one of the largest chlor-alkali manufacturers in Asia. The company supplies the plastic resins and an array of the basic chemicals that support modern life. Tosoh’s petrochemical operations supply ethylene, polyethylene, and functional polymers, while its advanced materials business serves the global semiconductor, display, and solar industries. Tosoh has also pioneered sophisticated bioscience systems that are used for the monitoring of life-threatening diseases. In addition, Tosoh demonstrates its commitment to a sustainable future in part by manufacturing a variety of eco-products.
Stock Exchange Ticker Symbol: 4042
DISCLAIMER
This document may contain forward-looking statements, including, without limitation, statements concerning product development, objectives, goals, and commercial introductions, which involve certain risks and uncertainties. Forward-looking statements are identified through the use of the word anticipates and other words of similar meaning. Actual results may differ significantly from the results expressed in forward-looking statements.